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Introduction
Procalcitonin (PCT) is the precursor of calcitonin, and is 
normally produced in the C-cells of the thyroid gland.1 
During systemic and severe infections, PCT is also pro-
duced rapidly in other tissues, and serum PCT concen-
trations increase to very high levels.2,3 Assicot et al first 
described PCT as an inflammation-induced protein 
in 1993.4 Since then, numerous clinical studies have 
demonstrated the utility of this marker. PCT is more 
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BACKGROUND/PURPOSE: The efficacy of the rapid semi-quantitative procalcitonin (PCT) test for the 
diagnosis of bacterial infection was evaluated in patients with systemic inflammatory response syndrome.
METHODS: A retrospective observational study was performed from June to December 2008 at the 
Chugoku Rosai General Hospital, Japan. This study analyzed consecutive patients (both outpatients and 
inpatients) who developed systemic inflammatory response syndrome and whose PCT test was measured 
semi-quantitatively within 24 hours of onset, or at the first hospital visit. Based on the clinical diagnosis, 
the patients were divided into two groups. Group I comprised patients with a bacterial infection, and 
group II comprised patients with a non-bacterial infection, or non-infectious disease. Receiver operating 
characteristic curves were used to evaluate the diagnostic value of the semi-quantitative PCT test kit, 
C-reactive protein levels and white blood cells counts for the detection of bacterial infections, and the 
areas under the resulting curves were compared.
RESULTS: A total of 168 patients were included and divided into groups I (n = 112) and II (n = 56). Group I 
showed a significantly higher percentage of positive PCT tests (≥ 0.5 ng/mL) than group II (67.8% vs. 19.6%, 
p < 0.001). PCT showed a sensitivity of 67.8% [95% confidence interval (CI) = 58.4–76.4] and a specificity of 
80.4% (95% CI = 67.6–89.8). The areas under the resulting curves for PCT (0.764) were significantly larger 
than those seen for C-reactive protein (0.650, p = 0.02) and white blood cells (0.618, p = 0.006).
CONCLUSION: The semi-quantitative PCT test is as useful for distinguishing bacterial infection from 
other inflammatory diseases in common clinical practice as the quantitative PCT.
KEYWORDS: C-reactive protein, diagnostic accuracy, inflammation marker, procalcitonin, white blood 
cell counts
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specific for detecting bacterial infection than other in-
flammatory markers, such as C-reactive protein (CRP) 
and white blood cell counts (WBC), because viral infec-
tions, autoimmune and allergic disorders do not induce 
PCT.5,6
Systemic inflammatory response syndrome (SIRS) is 
a new concept of inflammation that was suggested in 
1991 to detect patients likely to develop severe sepsis.7 
Determining whether a bacterial infection is present in 
a patient with SIRS can be the first step to appropriate 
treatment. However, clinicians often have difficulty with 
the diagnosis because SIRS can have various causes. 
Therefore, developing a diagnostic method that can de-
tect a bacterial infection easily and rapidly would be very 
helpful.
Measurement of PCT is common worldwide, and quan-
titative and semi-quantitative methods for measuring this 
marker have been available in Japan since 2006. There 
have been several studies that have evaluated the usefulness 
of quantitative PCT measurements for the diagnosis of 
bacterial infections in patients with SIRS.8,9 However, the 
usefulness of the semi-quantitative PCT test kit has not 
been suitably evaluated. We compare the semi-quantitative 
PCT test, which can be performed easily at the bedside 
and require only small amount of blood samples, with 
CRP and WBC for the diagnosis of bacterial infections in 
patients with SIRS.
Methods
Patients
A single-center retrospective observational study was per-
formed from June 1 to December 18, 2008 at the Chugoku 
Rosai General Hospital, Hiroshima, Japan. This urban hos-
pital primarily serves a general population and has about 
8,000 admissions each year. This study analyzed consecu-
tive patients (outpatients and inpatients) that developed 
SIRS, and a semi-quantitative PCT test was performed 
within 24 hours of onset, or at the first visit to hospital. 
Patients younger than 15 years of age were excluded. SIRS 
was defined by two or more of the following objective 
measurements: body temperature > 38°C or < 36°C; heart 
rate > 90 beats/min; respiratory rate > 20 breaths/min or 
PaCO2 < 32 mmHg; WBC > 12 ˜  109/L or < 4 ˜  109/L or 
> 10% immature forms.
On the basis of the final clinical diagnosis, the patients 
were divided into two groups: group I comprised those 
patients with a bacterial infection, and group II comprised 
those with a non-bacterial infection or a non-infectious 
disease. When there was no evidence of a non-bacterial in-
fection or a non-infectious disease, a clinical diagnosis of 
bacterial infection was established if causative bacteria 
were isolated from various samples (blood cultures, spu-
tum, pus, stool, or urine), if serum or urine samples were 
positive for bacterial antigens (e.g. Streptococcus pneumoniae 
and Legionella), or if the patient was strongly suspected 
of having a bacterial infection according to clinical data 
and their clinical course as determined by the attending 
physician. Any patient who could not be categorized into 
either of the groups was excluded.
Measurements
Serum PCT levels were measured in all patients using the 
PCT-Q test kit (BRAHMS, Germany). This test kit is based 
on the immunochromatographic principles for semi-
quantitative determination of PCT. The test procedure is 
carried out on non-hemolyzed blood samples that have 
been centrifuged. Briefly, 200 μL of serum is pipetted into 
the round cavity of the test trip. The tracer binds to any 
PCT in the sample and a marked antigen-antibody com-
plex is formed. This complex moves by means of capillary 
action through the test system, and in the process, passes 
through an area containing the test band. Here, the 
marked antigen-antibody complex binds to the fixed anti-
calcitonin antibodies and forms a sandwich complex. At a 
PCT level of ≥ 0.5 ng/mL, this sandwich complex can be 
seen as a reddish band.
The color intensity of the band is directly proportional 
to the PCT concentration of the sample, and it is related 
to different PCT level ranges (≥ 0.5 ng/mL, ≥ 2.0 ng/mL, 
≥ 10 ng/mL) with the help of a reference card. Non-bound 
tracer diffuses into the control band zone, where it is fixed 
and produces an intense red control band. The functional 
ability of the test system is then checked by means of this 
control band. After an incubation period of 30 minutes, 
the results are observed and the serum PCT concentration 
ranges are determined by comparing the color intensity 
of the band with the color blocks on the reference card. 
Usually, a PCT level ≥ 0.5 ng/mL is considered to be posi-
tive for the diagnosis of a bacterial infection.
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For the measurement of CRP, a latex agglutinating 
immunoassay reagent, LZ test “EIKEN” CRP (EIKEN 
Chemicals, Tokyo, Japan), was applied to an automatic 
biochemical analyzer (TBA-c8000, Toshiba, Tokyo, Japan) in 
the hospital biochemistry laboratory. WBC were measured 
in the hospital hematology laboratory.
Statistical analysis
Continuous variables were compared using the Mann-
Whitney U test. Categorical variables were compared using 
the χ2 test (Fisher’s exact test was used when applicable). 
To compare the clinical value of PCT, CRP, and WBC for 
detecting bacterial infections, receiver-operating char-
acteristic (ROC) curves were drawn and the areas under 
the curves (AUC) were compared. All values of p < 0.05 
were considered statistically significant. MedCalc 10.0 for 
Windows (MedCalc Software, Mariakerke, Belgium) was 
used for the analysis.
Results
The characteristics, clinical data and diagnoses of the pa-
tients in each group are shown in Tables 1–3. Respiratory 
infections (57/112; 50.9%) and abdominal infections (39/
112; 34.8%) accounted for the majority of the patients in 
group I (Table 2). Group II included patients with malig-
nant diseases, viral infections, drug-induced inflammation 
and allergic diseases (Table 3). As shown in Table 1, age, CRP, 
Table 1. Clinical data of the patients in this studya
 Group I (n = 112) Group II (n = 56) p
Sex, male 71 (63.4) 41 (73.2) 0.690
Age (yr) 76 (16–99) 69 (19–94) 0.009
PCT (ng/mL)
 < 0.5 36 (32.1) 45 (80.4) 0.001
 0.5–1.9 24 (21.4) 7 (12.5)
 2.0–9.9 22 (19.6) 2 (3.6)
 ≥ 10 30 (26.8) 2 (3.6)
 Positive (≥ 0.5) 76 (67.8) 11 (19.6) 0.001
CRP (mg/dL)  12.2 (0.06–36.50) 8.0 (0.08–25.70) 0.002
WBC (˜ 109/L) 10.96 (1.34–28.87) 9.04 (4.28–22.81) 0.013
Blood culture collection 67 (59.8) 20 (35.7) 0.005
Positive blood culture 26 1b 0.005
Death within 30 days of onset or first visit 17 (15.2) 4 (7.1) 0.210
aData presented as n (%), median (range) or n; bpatient with fungemia. PCT = Procalcitonin; CRP = C-reactive protein; WBC = white blood cells 
counts.
Table 2. Clinical diagnoses of Group I patients (n = 112)a
Diagnosis 
Respiratory infection Abdominal infection Urinary infection Othersb
 (n = 57) (n = 39) (n = 9) (n = 7)
PCT ≥ 0.5 (ng/mL) 30 (52.6) 34 (87.2) 7 (77.8) 5 (71.4)
CRP (mg/dL) 12.50 (1.10–36.50) 8.40 (0.06–33.30) 12.90 (0.95–18.90) 24.10 (3.00–27.80)
WBC count (˜ 109/L) 10.93 (1.91–28.87) 11.44 (1.34–27.37) 9.94 (6.67–17.63) 13.61 (6.45–26.32)
aData presented as n (%) or median range; bothers include cases of soft tissue infection, endocarditis, catheter infection, and meningitis. 
PCT = Procalcitonin; CRP = C-reactive protein; WBC = white blood cells.
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WBC and the number of positive blood cultures all showed 
statistically significant differences between the two groups.
A significantly higher percentage of positive (≥ 0.5 ng/
mL) PCT tests were observed in group I than group II 
(67.8% vs. 19.6%, p < 0.001). Overall, the PCT test showed a 
specificity of 80.4% for detecting bacterial infections. In 
group II, 11 patients had false-positive results. Although 
the majority of them had a slightly increased PCT level 
(≥ 0.5 ng/mL and < 2.0 ng/mL), four of the patients (2 with 
malignant disease, 1 with thyroid storm, and 1 with non-
ketotic hyperglycemic-hyper-osmolar coma showed high 
PCT (≥ 2.0 ng/mL) values. Moreover, different sensitivities, 
specificities, positive predictive values, and negative pre-
dictive values were observed when the cutoff values were 
changed to ≥ 2.0 ng/mL and ≥ 10 ng/mL (Table 4). On anal-
ysis of the infected organs, the percentage of positive PCT 
tests was significantly lower in those patients with respi-
ratory infection than in those with other organ infections 
Table 3. Clinical diagnoses of Group II patients (n = 56)a
 
Malignant disease Viral infection Allergic disease 
Drug-induced
 Othersb
Diagnosis    inflammation 
 
(n = 12) (n = 12) (n = 5)
 (n = 5)
 (n = 22)
PCT ≥ 0.5 (ng/mL) 4 (33.3) 2 (16.7) 1 (20.0) 0 4 (18.2)
CRP (mg/dL) 13.90 (1.70–22.10) 4.90 (0.08–16.70) 6.40 (3.90–22.10) 9.20 (1.20–12.70) 4.20 (0.14–25.70)
WBC count 11.59 8.12 6.70 8.58 9.63
 (˜ 109/L) (6.71–22.81) (4.28–14.67) (5.38–7.48) (5.63–17.65) (5.17–20.44)
aData presented as n (%) or median (range); bothers include cases of idiopathic interstitial pneumonia, endocrine disease, cardiac disease, 
trauma, fungal infection and pancreatitis. PCT = Procalcitonin; CRP = C-reactive protein; WBC = white blood cells.
Table 4. Diagnostic performance of the semi-quantitative procalcitonin test, C-reactive protein and white blood cells counts for 
the diagnosis of bacterial infectiona
Cutoff value Sensitivity Specificity Positive predictive value  Negative predictive value
PCT (ng/mL)
 ≥ 0.5  67.8 (58.4–76.4) 80.4 (67.6–89.8) 87.4 (78.5–93.5) 55.6 (44.1–66.6)
 ≥ 2.0 46.4 (37.0–56.1) 92.9 (82.7–98.0) 92.9 (82.7–98.0) 46.4 (37.0–56.1)
 ≥ 10.0 26.8 (18.9–36.0) 96.4 (87.7–99.5) 93.7 (79.2–99.1) 39.7 (31.4–48.4)
CRP (18.5 mg/dL) 37.5 (28.5–47.1) 92.9 (82.7–98.0) 91.3 (79.2–97.5) 42.6 (33.7–51.9)
WBC count (9.13 ˜  109/L) 74.1 (65.0–81.9) 51.8 (38.0–65.3) 75.5 (66.3–83.2)   50 (36.6–63.4)
aData presented as % (95% confidence interval). PCT = Procalcitonin; CRP = C-reactive protein; WBC = white blood cells.
(52.6% vs. 83.6%, p < 0.001), despite relatively high CRP levels 
and WBC.
Analysis of the ROC curves revealed AUCs of 0.764 
for PCT, 0.650 for CRP, and 0.618 for WBC (Figure). 
Comparison of the AUC for PCT with those of CRP (p = 
0.02) and WBC (p = 0.006) showed a statistically signifi-
cant difference. At the best cutoff values for PCT (0.5 ng/
mL), CRP (18.5 mg/dL), and WBC (9.13 × 109/L), the sen-
sitivity and specificity were 67.8% and 80.4%, 37.5% and 
92.9%, 74.1% and 51.8%, respectively.
Discussion
In the current study, PCT showed a significantly higher 
positive rate of detection in patients with bacterial infec-
tion than in other patients. In addition, a comparison of 
the AUC showed that PCT has a greater diagnostic value 
than CRP and WBC.
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This study has two limitations. First, the clinicians 
were not blind to the PCT test results. Therefore, several 
clinicians might have been influenced by the PCT test 
results when they determined whether a bacterial infec-
tion was present in the patients. The diagnostic value of 
PCT might have been overestimated. Second, it was un-
necessary to identify the causative bacteria in the diag-
nosis of a bacterial infection. Because we tried to evaluate 
the value of PCT in common clinical practice, those pa-
tients in whom the PCT test was carried out were included 
whenever possible. As a result, patients with a spurious 
bacterial infection could have been included in group I 
and the diagnostic value of PCT might have been under-
estimated. Nevertheless, it is interesting to note that PCT 
showed greater a diagnostic value than either CRP or WBC 
despite such an unfavorable situation.
The sensitivity and specificity of PCT can be changed 
depending on the study population, cutoff value etc. For 
example, in a study involving a lot of severely ill patients, 
PCT shows high sensitivity. The current study included 
patients with SIRS who are encountered routinely in com-
mon clinical practice, a lot of patients with mild bacterial 
infections were included. Therefore the sensitivity of PCT 
was not high. Aikawa et al and Delèvaux et al assessed the 
diagnostic value of quantitative PCT measurement in pop-
ulations similar to those in the current study.8,9 Although 
the specificity was somewhat inferior, the performance of 
the semi-quantitative PCT tests in the current investiga-
tion (sensitivity = 67.8%; specificity = 80.4%) was similar to 
that seen in their reports (cutoff value = 0.5 ng/mL; sensi-
tivity = 64.4–65.0%; specificity = 86.4–96.0%). When a PCT 
measurement is used in a patient with SIRS, it has low 
sensitivity and high specificity for detecting bacterial 
infections. In other words, this marker is ineffective for 
screening for bacterial infections, but is useful for defini-
tive diagnosis. A patient with a positive PCT test must, 
therefore, be suspected of having a bacterial infection, 
and blood cultures and antibacterial therapy are strongly 
recommended. If PCT shows higher levels (≥ 2.0 ng/mL 
or ≥ 10 ng/mL), this suspicion becomes even stronger. 
In contrast, one cannot rule out a bacterial infection in 
a patient with a negative PCT test. In this case, further 
examinations must be undertaken to determine the pres-
ence of a bacterial infection.
The present study showed major difference in the sen-
sitivity of the semi-quantitative PCT test between respi-
ratory infections and other organ infections. We think 
one of the reasons is that the frequency of involvement of 
Gram-positive bacteria in respiratory infection is higher 
than in other organ infection. Gram-positive bacterial 
infection tends to remain local inflammation, compared 
to Gram-negative bacterial infection that is susceptible to 
endotoxin shock. Several investigators have reported that 
serum PCT levels tend to be higher during episodes of sys-
temic inflammation or Gram-negative bacterial infection 
than those of local inflammation or Gram-positive bacte-
rial infection.10,11
Clinical simplicity and speed are the greatest advan-
tages of the semi-quantitative PCT test. This kit is there-
fore useful for the diagnosis of patients with SIRS in an 
emergency room, or under-equipped medical clinics. How-
ever, there are several disadvantages compared with quan-
titative PCT measurements. First, the diagnostic precision 
of the semi-quantitative PCT test kit is inferior to that of 
quantitative PCT measurements because the results must 
be determined visually.12,13 Laboratory technicians must 
decide between either the next lower or higher category at 
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Figure. Receiver operating characteristic curves for the semi-
quantitative procalcitonin test, C-reactive protein, and white 
blood cell counts used for the diagnosis of bacterial infection. 
AUC = Area under the curve; SE = standard error; CI = confidence 
interval; CRP = C-reactive protein, PCT = procalcitonin; WBC = 
white blood cells counts.
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borderline levels. This could introduce a large error if they 
are not skilled in of the use of this kit. The specificity found 
in this study was lower than that found for quantitative 
PCT measurements in past reports because the decision 
as to whether a PCT value of ≥ 0.5 ng/mL could be subjec-
tive when using the semi-quantitative PCT test. Second, 
the semi-quantitative PCT test may be a poor tool for se-
quential evaluation of a patient’s condition because the 
test kit only provides an estimate of serum PCT levels.13 
Serum PCT levels are occasionally increased to ≥ 100 ng/
mL in patients with severe bacterial infections. Naturally, 
such a patient would be judged as having a PCT level 
≥ 10 ng/mL by the semi-quantitative PCT test kit. After 
treatment, the level will remain at ≥ 10 ng/mL according 
to this test kit if the serum PCT levels do not decrease 
to < 10 ng/mL, despite an improvement in the patients’ 
condition. In such situations, other quantitative inflam-
matory markers (e.g. CRP and WBC) may be more useful.
Because the value of measuring PCT in the manage-
ment of infectious disease is obvious, it is hoped that 
quantitative PCT measurements can be extensively ap-
plied in the near future. However, the results of the cur-
rent study suggest that the rapid semi-quantitative PCT 
test kit is sufficient to accurately diagnose bacterial infec-
tions in common clinical practice.
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